Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Clarinex tablets with Allegra tablets in seasonal allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allegra (fexofenadine)
  • Clarinex (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED